---------- Forwarded message ----------
From: U.S. Food & Drug Administration (FDA) <fda@service.govdelivery.com>
Date: Tue, Sep 2, 2014 at 8:55 AM
Subject: CDER New September 2, 2014
To: iammejtm@gmail.com
From: U.S. Food & Drug Administration (FDA) <fda@service.govdelivery.com>
Date: Tue, Sep 2, 2014 at 8:55 AM
Subject: CDER New September 2, 2014
To: iammejtm@gmail.com
What's New on the FDA Drugs Site
August 29, 2014
- CDER Key Officials List (PDF - 125KB) (updated)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- National Drug Code Directory
- Pediatric Exclusivity Granted (updated)
New and Generic Drug Approvals
August 28, 2014
Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
---|---|---|---|---|
Aleve Pm | diphenhydramine hydrochloride; naproxen sodium | Tablet;Oral | Bayer Hlthcare | Labeling Revision |
Avonex | interferon beta-1a | Vial | Biogen | Labeling Revision |
Decitabine | decitabine | Injectable;Injection | Sandoz Inc | Approval |
Ella | ulipristal acetate | Tablet;Oral | Lab Hra Pharma | Labeling Revision |
Frovatriptan Succinate | frovatriptan succinate | Tablet;Oral | Mylan Pharms Inc | Approval |
Ifex | ifosfamide | Injectable;Injection | Baxter Hlthcare | Labeling Revision |
Ifex/Mesnex Kit | ifosfamide; mesna | Injectable;Injection | Baxter Hlthcare | Labeling Revision |
Lamivudine and Zidovudine | lamivudine;zidovudine | Tablet;Oral | Mylan Pharms Inc | Approval |
Metformin Hydrochloride | metformin hydrochloride | Tablet;Oral | Zydus Hlthcare | Approval |
Oxycodone; Acetaminophen | oxycodone;acetaminophen | Tablet;Oral | Rhodes Pharms | Approval |
Requip | ropinirole hydrochloride | Tablet;Oral | Glaxosmithkline Llc | Labeling Revision |
Requip Xl | ropinirole hydrochloride | Tablet, Extended Release;Oral | Glaxosmithkline Llc | Labeling Revision |
Rimso-50 | dimethyl sulfoxide | Solution;Intravesical | Mylan Institutional | Manufacturing Change or Addition |
Stavzor | valproic acid | Capsule, Delayed Release;Oral | Banner Pharmacaps | Labeling Revision |
Stribild | cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate | Tablet;Oral | Gilead Sciences Inc | Efficacy Supplement with Clinical Data to Support |
This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |
Jeremy Tobias Matthews
No comments:
Post a Comment